Wealthcare Advisory Partners LLC Amphastar Pharmaceuticals, Inc. Transaction History
Wealthcare Advisory Partners LLC
- $3.43 Billion
- Q3 2024
Shares
4 transactions
Others Institutions Holding AMPH
# of Institutions
283Shares Held
35.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$289 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$130 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$104 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$94.5 Million0.19% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$78.8 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.38B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...